Change text size: A | A | A

Binocular Visual Acuity

A full range of clear vision

Comparison of mean defocus curves for AcrySof^® IQ ReSTOR^® IOLs 3 months postoperatively after binocular implantation.¹

Distance Visual Acuity

Studies show that the AcrySof^® IQ ReSTOR^® IOL provides excellent near visual acuity without compromising distance visual acuity. In a recent study, 99% of patients who received the AcrySof^® IQ ReSTOR^® IOL bilaterally and 98% of those who received the monofocal IOL bilaterally (control group) achieved distance visual acuity of 20/40 or better without correction.

Additionally, 88% of patients who received the AcrySof^® IQ ReSTOR^® IOL achieved distance visual acuity of 20/25 or better without contacts or glasses, compared to 92% of the monofocal wearers. This indicates that the two lenses were statistically equivalent in distance visual acuity.

Near Visual Acuity

74% of patients receiving the AcrySof^® IQ ReSTOR^® IOL bilaterally achieved near visual acuity of 20/25 or better without correction by contacts or glasses, while only 14% of the bilateral monofocal control group achieved this level. At this level, patients can read the normal type in a newspaper.

In addition, 85% of the AcrySof^® IQ ReSTOR^® IOL patients achieved functional uncorrected intermediate vision of 20/40 at 60 cm. 20/40 is the requirement to pass the vision test for a driver's license in most states.

The unique apodized diffractive optic design of the AcrySof^® IQ ReSTOR^® IOL enables this exceptional visual performance, without physical movement of the lens inside the eye.

AcrySof^® IQ ReSTOR^® IOL Package Insert

Focus^™ Magazine

Get the full story on cataract surgery – request your complimentary copy now!

Practice Performance

This Practice Performance Zone is the online companion to the Premium Lens practicePAK. Here you will find electronic versions of all the items discussed in the practicePAK as well as new items as they become available.

Home Invite a Colleague Site Map CataractSurgery.com

Copyright © 2010 Alcon, Inc. a global company based in Hünenberg, Switzerland. The information and materials within this section pertain to the U.S. market only. Not all products are approved in every market, and approved labeling and instructions may vary by local country. See Privacy Policy and Terms & Conditions for the use of this site.

This Website may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional.

Other Alcon Informational Websites:

Glaucoma Eye vitamins Allergy eyes Nasal allergies Ear infection treatment Cataract surgery Dry eye Contact lens solution

CAUTION: Federal law restricts this device to sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ ReSTOR® Apodized Diffractive Optic Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag.

WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Physician Labeling. Some adverse reactions that have been associated with the implantation of intraocular lenses are: hypopyon, intraocular infection, acute corneal decompensation, macular edema, pupillary block, retinal detachment, and secondary surgical intervention (including but not limited to lens repositioning, biometry error, visual disturbances or patient dissatisfaction). As a result of the multifocality, some visual effects (halos or radial lines around point sources of light at night) may also be expected due to the superposition of focused and unfocused multiple images. A reduction in contrast sensitivity may also be experienced by some patients, especially in low lighting conditions such as driving at night. In order to achieve optimal visual performance with this lens, emmetropia must be targeted. Patients with significant preoperative or expected postoperative astigmatism >1.0D may not achieve optimal visual outcomes. Care should be taken to achieve IOL centration, as lens decentration may result in a patient experiencing visual disturbances under certain lighting conditions.

PRECAUTIONS: Do not resterilize. Do not store over 45° C. Use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solution. Clinical studies with the AcrySof® IQ ReSTOR® IOL indicated that posterior capsule opacification (PCO), when present, developed earlier into clinically significant PCO. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. The long-term effects of filtering blue light and the clinical efficacy of that filtering on the retina have not been conclusively established.